third contracts a of at development payment large we costs, secured product our We most states. by We Pear continue the drive grew and pipeline on for on operating intersection sustainability. We today segment this opportunities In third more joining than XXXX the business, on as of continues again and the quarter-over-quarter. we us we improved focused metrics you, to our the Pear’s Thank number addiction mature quarter reduce grow. towards And our products and revenue and of commercial commercial our thanks resources of discuss specifically results. once revenue XX% intersection growth, drive everyone and Ronan. quarter, to
to continue several to We and reinforcing business, and in current lower value at well capital, product platforms. at call, federal our candidates base, our evidence areas scarce such payers, prudent commercial our increased and engagement, to this in clinical patient option costs. other as today's reduction be Somryst, of all our that cost. any of value thread cost lower including less outcomes payers, cost our We burn. would force, pipeline main real-world maintain, I'll and cash published We to of what triple grow proposition In try can accomplish of as it restructured expensive the improved additional of we dual environment
Pear announced afternoon. demonstrating first it I'll can So force in few at expenses we mind, reduction is about cost. a and revenue, lower about grow say then a operating earlier in With few a this that words
make software a where mainstream spend on a out I'll minutes journey to Finally, are few medicine. we mapping our
revenue. First,
continue We each to revenue quarter. grow
patients $X.X quarter. strong with XX,XXX million. and in from the than quarter posting This more Demand providers prescriptions is
requires revenue into scripts things. Turning two
provide density. with and coverage targeting payers sufficient access; who second, First, adding regions
programs innovative more to the healthcare them reSET that and Carolina, are our funding. treatment covered awarded payer believe North our prioritized most are the like Most temporarily tackle States societal billion federal to allocated epidemic to Ohio, by coverage, Response our where value now see performance with are compelling. years and for alone. prescribing our State patients and business, response, and Massachusetts, positive by have products. both funds states rate. Kentucky, with on our This drive quarter, of include providing that our indicative believe states particularly looking of money being Wisconsin. Medicaid addiction. selling we last world providers rate states. which Oklahoma, mature clinical In to upward $XX two state both States we who channel the proposition funding ten to and take reSET-O are and help Indiana, in Those is for is we payers settlement acted as Alabama, benefit. a costs paid save have by the exposed approaches We than is increased Carolina, have fundamentals and reSET payment associated payment earmarked of South to We in To patients support evidenced Michigan, real Opioid strong experience and reSET-O
states population Within by selling and crisis. our battle XX addiction significant states, from addiction. we term a robust states believe covered is patients to near of well With suffer by approximately positioned addiction begun to steadily these just revenue helping four with Pear We've unit the addiction grow only people states. economics, million products
products. now us commercial of large New a coverage, existing is membership with business. additional Pennsylvania, reSET within and Highmark, big payer to seeing a providing progress We're as Delaware, providing well. opportunity. our York products. just broaden states XXXX states, Pear’s As of plan coverage are that provide cover to our bringing a West reSET-O our XX three to New could piece states access States in Blue’s for all payers Excellus opportunity is to become also very Upstate Blue’s ten the expand Virginia, across we the and with and XX commercial York one all plans
Kaiser added plan Additionally, a formulary. to Massachusetts Massachusetts, top Tufts payer Colorado three in in us Health Plan in and
have signs health payers but opposition equity health Non-covering outliers, becoming see to that with are We parity. we and payers, standing building. do is mental in commercial work momentum much to
and take wish sustainability. potential, one announced future every opportunity landscape my with I of I PearConnect, been market dual we of publicly departing and that have but reduction business this we endeavors. Finally, the the balance them our to candidates we pipeline of the to space our These and Pear the our Leveraging to driving created, great towards we contributions represent the need gratitude and to significant with who product continues platforms, want And PearCreate hardworking, have team. in opportunity are long-term own opportunity to current value. our members valued each their success express clients. individuals countless of mission-driven talented in want our force. for to Today
mainstream and asks remains mission medicine, one software Our will mainstream reality. medicine. making No that that if making are a we become anymore PDTs steadily
when. they ask Now
last way. on our real-world and of evidence commercial months PDTs that in Our progress the well their continuum XX and are clinical demonstrates
revenue first time. This Last delivered revenue we product the as illustrates trajectory revenue we expect year for saw my Our point. we triple year, that. million to $X.X in
discuss Chris additional to turn next and Julia. proposition. products, on financial year, for sale our that patient our demonstrating And to this Next reSET driven our prescriber Yuri is revenue grow barriers it world progress, will will well steps from to operating fundraising strong upside over the real to new commercial To our data walk year's demand, double share And reliance The reduce in as remove patient year. Julia? states. case guidance reSET-O continue we've in be to and and will as outcomes. value predominantly of growth demonstrate significant access, taken could we Then is finally, guidance. as strong through metrics, I further more our
